Table 2.
Study | Region | LncRNA | Expression | Detected sample | Test method | Cut-off | Sample size
|
Survival analysis | HR availability | Follow-up month | NOS | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
High | Low | |||||||||||
Ariel et al, 200031 | Israel | H19 | Up-regulation | Tissue | RT-qPCR | NA | 16 | 14 | OS | Indirectly | 80 | 5 |
Wang et al, 201313 | China | UBC1 | Up-regulation | Tissue | RT-qPCR | FC >1.5 | 60 | 42 | OS MFS |
Indirectly Indirectly |
80 | 5 |
Li et al, 201432 | China | GHET1 | Up-regulation | Tissue | RT-qPCR | Median | 39 | 41 | OS | Indirectly | 60 | 6 |
Zhao et al, 201515 | China | SPRY4-IT1 | Downregulation | Tissue | RT-qPCR | Mean | 38 | 30 | OS | Directly | NA | 5 |
Martínez- Fernández et al, 201533 | Spain | HOTAIR | Up-regulation | Tissue | RT-qPCR | Median | 30 | 33 | PFS OS |
Indirectly Indirectly |
36 72 |
5 |
Chen et al, 201534 | China | n336928 | Up-regulation | Tissue | RT-qPCR | FC >2 | 44 | 51 | OS | Directly | 60 | 5 |
Heubach et al, 201535 | Germany | HOTAIR | Up-regulation | Tissue | RT-qPCR | FC >2 | 27 | 81 | DSS | Directly | 200 | 6 |
Duan et al, 201628 | China | MEG3 | Downregulation | Serum | RT-qPCR | NA | 26 | 33 | RFS | Indirectly | 57 | 7 |
Zhang et al, 201636 | China | UNMIBC | Up-regulation | Tissue | RT-qPCR | FC >1.5 | 42 | 33 | RFS | Directly | 36 | 6 |
Zhang et al, 201637 | China | GAS5 | Downregulation | Tissue | RT-qPCR | Median | 41 | 41 | DFS | Directly | 60 | 7 |
Shang et al, 201638 | China | HOTAIR | Up-regulation | Tissue | RT-qPCR | NA | 16 | 19 | OS | Indirectly | 40 | 5 |
Iliev et al, 201639 | Czech Republic |
TUG1 | Up-regulation | Tissue | RT-qPCR | NA | 26 | 21 | OS | Directly | 100 | |
Yan et al, 201723 | China | ASAP1-IT1 | Up-regulation | Tissue | RT-qPCR | Median | 19 | 19 | OS | Directly | 44 | 6 |
Droop et al, 201740 | Germany | MALAT1 TUG1 UCA1 UBC1 NcRAN GAS5 H19 |
Downregulation Downregulation Downregulation Downregulation Downregulation Downregulation Downregulation |
Tissue | RT-qPCR | Median | 53 | 53 | OS DSS |
Directly Directly |
200 200 |
6 |
Wang et al, 201741 | China | HULC | Up-regulation | Tissue | RT-qPCR | Median | 138 | 138 | RFS | Indirectly | 14 | 5 |
Zhuang et al, 201742 | China | LET | Downregulation | Tissue | RT-qPCR | Median | 30 | 30 | OS | Indirectly | 48 | 6 |
Abbreviations: DFS, disease-free survival; DSS, disease-specific survival; FC, fold change; lncRNA, long non-coding RNA; MFS, metastasis-free survival; NOS, Newcastle-Ottawa Scale; OS, overall survival; PFS, progression-free survival; RFS, recurrence-free survival.